Oramed Pharmaceuticals (ORMP) Interest Coverage Ratio Growth (3y) (2014 - 2026)
Oramed Pharmaceuticals (ORMP) Interest Coverage Ratio Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 29.79% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 33.30% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 78.77% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 81.16% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -35.50% |
| 10 | Oramed Pharmaceuticals | 197.61 Mn | 197.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.90% |
| Mar 31, 2026 | 64.57% |
| Dec 31, 2025 | 31.21% |
| Sep 30, 2025 | -28.13% |
| Jun 30, 2025 | -19.01% |
| Mar 31, 2025 | -235.47% |
| Aug 31, 2021 | -2,213.50% |
| Nov 30, 2019 | -19.86% |
| Aug 31, 2019 | 62.26% |
| May 31, 2019 | -134.57% |
| Feb 28, 2019 | -154.58% |
| Nov 30, 2018 | -247.02% |
| Aug 31, 2018 | 90.76% |
| May 31, 2018 | -31.93% |
| Feb 28, 2018 | 56.12% |
| Nov 30, 2017 | -14.59% |
| Aug 31, 2017 | 45.29% |
| May 31, 2017 | -28.40% |
| Feb 28, 2017 | 24.27% |
| Nov 30, 2016 | 48.93% |